TTNP icon

Titan Pharmaceuticals

25 hedge funds and large institutions have $633K invested in Titan Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

Holders
25
Holders Change
+3
Holders Change %
+13.64%
% of All Funds
0.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Truist Financial
1
Truist Financial
North Carolina
$404K 625,089
Renaissance Technologies
2
Renaissance Technologies
New York
$88K 135,610 +200 +0.1%
Vanguard Group
3
Vanguard Group
Pennsylvania
$53K 82,051
Geode Capital Management
4
Geode Capital Management
Massachusetts
$41.4K 63,965
State Street
5
State Street
Massachusetts
$24.8K 38,287
Citadel Advisors
6
Citadel Advisors
Florida
$19.2K 29,675 +29,675 New
TRCT
7
Tower Research Capital (TRC)
New York
$1.02K 1,573 -39 -2%
LFA
8
Level Financial Advisors
New York
$638 987
Group One Trading
9
Group One Trading
Illinois
$214 330
Bank of America
10
Bank of America
North Carolina
$133 206
Wells Fargo
11
Wells Fargo
California
$54 83 +5 +6%
Fidelity Investments
12
Fidelity Investments
Massachusetts
$40 62 -8 -11%
JPMorgan Chase & Co
13
JPMorgan Chase & Co
New York
$40 61
BlackRock
14
BlackRock
New York
$39 60
GWSA
15
Global Wealth Strategies & Associates
Colorado
$26 40
Osaic Holdings
16
Osaic Holdings
Arizona
$23 37
Morgan Stanley
17
Morgan Stanley
New York
$10 16 -12 -43%
WIM
18
Westside Investment Management
California
$3 4
NFSG
19
Newbridge Financial Services Group
Florida
$1 2
CIA
20
Cape Investment Advisory
Georgia
$1 1
CSC
21
Caldwell Sutter Capital
California
$1 2
DJSG
22
D.J. St. Germain
Massachusetts
$1 1 +1 New
NRG
23
Nemes Rush Group
Michigan
$1 1 +1 New
UBS Group
24
UBS Group
Switzerland
-1,526 Closed
CFGS
25
Concourse Financial Group Securities
Alabama